Phase 1 Trial of the Safety and Immunogenicity of PENNVAX ® -G DNA Prime Administered by Biojector ® 2000 or CELLECTRA ® EP Device with MVA-CMDR Boost
Ake, Julie, Ratto-Kim, Silvia, Schuetz, Alexandra, Wieczorek, Lindsay, Nguay, Viseth, Kibuuka, Hannah, Sawe, Fredrick, Maboko, Leonard, Polonis, Victoria, Weiner, David, DeSouza, Mark, Sekiziyivu, ArtТом:
30
Мова:
english
Журнал:
AIDS Research and Human Retroviruses
DOI:
10.1089/aid.2014.5398.abstract
Date:
October, 2014
Файл:
PDF, 70 KB
english, 2014
File converter
Більше результатів пошуку
More benefits 
